Corrigendum: Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients

Corrigendum: Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients

Saved in:

Bibliographic Details
Main Authors:	Jing Wang, Qiu Fang, Xuemei Luo, Lu Jin, Huaijun Zhu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Pharmacology
Subjects:	imipenem population pharmacokinetics dosing optimization elderly patients Monte Carlo
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1565995/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients
by: Jing Wang, et al.
Published: (2025-01-01)

High-Dose Ceftriaxone in Elderly Patients with Enterococcal Infective Endocarditis: Population Pharmacokinetics of Free Ceftriaxone and Dose Optimization
by: Beatriz Fernández Rubio, et al.
Published: (2025-05-01)

Population pharmacokinetics and dose optimization of voriconazole in patients with COVID-19-associated pulmonary aspergillosis
by: Hui Wang, et al.
Published: (2025-04-01)

Influential predictors of azithromycin pharmacokinetics: a systematic review of population pharmacokinetics
by: Janthima Methaneethorn, et al.
Published: (2025-12-01)

Clinical imipenem non-susceptible Klebsiella pneumoniae isolates from China: Epidemiology, molecular characterization and in vitro activity of imipenem/relebactam
by: Peiyao Jia, et al.
Published: (2025-09-01)

Development of a Population Pharmacokinetic Model of Levofloxacin in Healthy Adults and Identification of Optimal Dosing Regimens
by: Yun-Jung Lee, et al.
Published: (2025-04-01)

Model-guided development of pharmacokinetic/pharmacodynamic cut-offs and evaluation of sitafloxacin dosing regimens against target pathogens
by: Hailan Wu, et al.
Published: (2025-02-01)

A Population Pharmacokinetic Model to Inform Extension of the Eteplirsen Dosing Regimen Across the Broad DMD Population
by: Yogesh Patel, et al.
Published: (2025-05-01)

Population Pharmacokinetics and Pharmacodynamics of Sitafloxacin in Plasma and Alveolar Epithelial Lining Fluid of Critically Ill Thai Patients With Pneumonia
by: Taniya Paiboonvong, et al.
Published: (2025-04-01)

Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients
by: Xiping Li, et al.
Published: (2024-08-01)

Hospital-acquired pneumonia due to Achromobacter xylosoxidans in the elderly: A single-center retrospective study in Beijing
by: Chao Liu, et al.
Published: (2017-01-01)

Model-Informed Precision Dosing of Remimazolam in General Anesthesia Patients
by: Chen Y, et al.
Published: (2025-06-01)

AmpC induction by imipenem in Pseudomonas aeruginosa occurs in the absence of OprD and impacts imipenem/relebactam susceptibility
by: Shawn Freed, Jr, et al.
Published: (2024-11-01)

Pharmacokinetics of Vancomycin in Healthy Korean Volunteers and Monte Carlo Simulations to Explore Optimal Dosage Regimens in Patients with Normal Renal Function
by: Yong Kyun Kim, et al.
Published: (2024-10-01)

CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
by: I. I. Shteynberg, et al.
Published: (2015-03-01)

Fluconazole Dosing for the Prevention of <i>Candida</i> spp. Infections in Hemato-Oncologic Pediatric Patients: Population Pharmacokinetic Modeling and Probability of Target Attainment Simulations
by: Arkadiusz Adamiszak, et al.
Published: (2025-04-01)

SYNERGISTIC EFFECTS OF ETHYLENE DIAMINE TETRA ACETIC ACID AND IMIPENEM AGAINST Pseudomonas aeruginosa WERE ISOLATED FROM CHEESE IN HILLA PROVINCE.
Published: (2018-12-01)

Pharmacokinetic/pharmacodynamic modeling in plasma and milk and Monte Carlo simulations of marbofloxacin against Staphylococcus aureus and Mycoplasma agalactiae in lactating sheep
by: J.M. Serrano-Rodríguez, et al.
Published: (2025-05-01)

A novel gene linked to Imipenem resistance in E. coli isolate lacking known Imipenem-resistance genes
by: Trang Thu Hoang, et al.
Published: (2025-03-01)

Resistance characterization and transcriptomic analysis of imipenem-induced drug resistance in Escherichia coli
by: Chunyu Tong, et al.
Published: (2024-11-01)

Optimizing Lidocaine Dosing in Hepatectomy Patients: A Population Pharmacokinetic Study of Active Metabolites
by: He C, et al.
Published: (2025-07-01)

Population pharmacokinetics
by: Milovanović Jasmina R., et al.
Published: (2005-01-01)

Pharmacokinetics and pharmacodynamics of ciprofol after continuous infusion in elderly patients
by: Xiaowen Guo, et al.
Published: (2025-01-01)

Investigating Remedial Strategies for Missed or Delayed Dose of Sertraline in Chinese Adolescent Patients with Depressive Disorders via Population Pharmacokinetics Modeling and Simulation Approaches
by: Xia H, et al.
Published: (2025-04-01)

Population pharmacokinetics and dose optimization of ceftazidime in critically ill children
by: Mengting Li, et al.
Published: (2024-11-01)

Middle‐Out Physiologically Based Pharmacokinetic Modeling to Support Pediatric Dosing Recommendation for Alectinib
by: Tamara vanDonge, et al.
Published: (2025-06-01)

Vancomycin dosing in neonates: enhancing outcomes using population pharmacokinetics and simulation
by: Sílvia M. Illamola, et al.
Published: (2025-05-01)

Parametric Population Pharmacokinetics Model Repository of Rifampicin: Model-Informed Individualized Therapy
by: Ju G, et al.
Published: (2025-04-01)

Imipenem/cilastatin encapsulation in UIO-66-NH2 carrier as a new strategy for combating imipenem-resistant Pseudomonas aeruginosa isolates
by: Shakila Baei Lashaki, et al.
Published: (2025-05-01)

Estudo preliminar da dose absorvida e efetiva da cisplatina radiomarcada
by: Alexandre Soares Leal, et al.
Published: (2020-03-01)

Dosing Regimen Recommendations for Sirolimus in Adult Liver Transplant Recipients: Insights from a Population Pharmacokinetic Model
by: Mao J, et al.
Published: (2024-12-01)

High incidence of MBL-mediated imipenem resistance among Pseudomonas aeruginosa from surgical site infections in Egypt
by: Marian R Raouf, et al.
Published: (2018-07-01)

Activity of imipenem/relebactam against KPC-producing Klebsiella pneumoniae and the possible role of Ompk36 mutation in determining resistance: an Italian retrospective analysis
by: Emanuele Palomba, et al.
Published: (2025-04-01)

Utilizing Physiologically Based Pharmacokinetic Models to Support Rational Medication in Chinese Elderly Population
by: Wu X, et al.
Published: (2025-04-01)

In vitro activity of imipenem/relebactam and comparators against Enterobacterales isolates collected in Brazilian hospitals according to results from the Study for Monitoring Antimicrobial Resistance Trends, 2020–2021
by: Amanda Azevedo Bittencourt, et al.
Published: (2025-07-01)

Optimization of meropenem dosing regimens in critically ill patients with augmented renal clearance
by: Jinfeng Luo, et al.
Published: (2025-05-01)

Pharmacokinetic/pharmacodynamic analysis of tedizolid phosphate against Staphylococcus aureus and Streptococcus pneumoniae in children, adolescents, and adults by Monte Carlo simulation
by: Xiao-Chen Wei, et al.
Published: (2025-01-01)

Population Pharmacokinetic and Exposure–Response Analyses for Ponatinib in the Phase 3 PhALLCON Study
by: Michael J. Hanley, et al.
Published: (2025-03-01)

The sedation efficacy of different doses of remimazolam in elderly patients with regional nerve block anaesthesia
by: Wan-jun Yang, et al.
Published: (2024-12-01)

Efficacy of imipenem combined with dimercaptosuccinic acid in a murine sepsis model using Pseudomonas aeruginosa
by: Soraya Herrera-Espejo, et al.
Published: (2025-08-01)